Differential transcriptional expresion of the polymorphic myxovirus resistance protein A in response to interferonalpha treatment

被引:18
作者
Fernández-Arcás, N
Blanco, A
Gaitán, J
Nyqvist, M
Alonso, A
Reyes-Engel, A [1 ]
机构
[1] Univ Malaga, Fac Med, Dept Biochem & Mol Biol, E-29071 Malaga, Spain
[2] Carlos Haya Hosp, Serv Immunol, Malaga, Spain
来源
PHARMACOGENETICS | 2004年 / 14卷 / 03期
关键词
quantitative MxA expression; -88G/T SNP; real time RT-PCR;
D O I
10.1097/01.fpc.0000114718.42625.a1
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Levels of myxovirus resistance protein A (MxA) mRNA were studied for a single nucleotide polymorphism in the promoter region at nucleotide position -88 of the gene to identify individual-specific responses to interferon (IFN)-alpha(2) that might predict responsiveness to IFN-alpha therapy. We quantified MxA expression by reverse transcription and real-time polymerase chain reaction in peripheral blood mononuclear cells (PBMC) in vitro, induced by IFN-alpha(2), from 22 healthy donors, in relation with G/T polymorphism located in the promoter of the MxA. MxA mRNA was significantly upregulated in all subjects (mean of 53-fold) in response to IFN-alpha(2) in vitro (P < 0.01). Comparison of the inducibility of MxA mRNA expression in relation with G/T polymorphism showed a 4.26-fold higher induction of MxA mRNA levels in PBMC from carriers of the mutant allele (GT or TT) than homozygotes with the wild-type allele (GG) (P < 0.001). We propose that expression of the IFN-inducible MxA is affected by a single nucleotide polymorphism in the MxA promoter which can identify an individual response to IFN-alpha(2). (C) 2004 Lippincott Williams Wilkins.
引用
收藏
页码:189 / 193
页数:5
相关论文
共 28 条
[1]   Correlation of interferon-induced expression of MxA mRNA in peripheral blood mononuclear cells with the response of patients with chronic active hepatitis C to IFN-α therapy [J].
Antonelli, G ;
Simeoni, E ;
Turriziani, O ;
Tesoro, R ;
Redaelli, A ;
Roffi, L ;
Antonelli, L ;
Pistello, M ;
Dianzani, F .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1999, 19 (03) :243-251
[2]   Evaluation of bioavailability of three types of IFNβ in multiple sclerosis patients by a new quantitative-competitive-PCR method for MxA quantification [J].
Bertolotto, A ;
Gilli, F ;
Sala, A ;
Audano, L ;
Castello, A ;
Magliola, U ;
Melis, F ;
Giordana, MT .
JOURNAL OF IMMUNOLOGICAL METHODS, 2001, 256 (1-2) :141-152
[3]   Chronic myeloid leukemia and interferon-α:: a study of complete cytogenetic responders [J].
Bonifazi, F ;
de Vivo, A ;
Rosti, G ;
Guilhot, F ;
Guilhot, J ;
Trabacchi, E ;
Hehlmann, R ;
Hochhaus, A ;
Shepherd, PCA ;
Steegmann, JL ;
Kluin-Nelemans, HC ;
Thaler, J ;
Simonsson, B ;
Louwagie, A ;
Reiffers, J ;
Mahon, FX ;
Montefusco, E ;
Alimena, G ;
Hasford, J ;
Richards, S ;
Saglio, G ;
Testoni, N ;
Martinelli, G ;
Tura, S ;
Baccarani, M .
BLOOD, 2001, 98 (10) :3074-3081
[4]   The MxA protein levels in whole blood lysates of patients with various viral infections [J].
Chieux, V ;
Hober, D ;
Harvey, J ;
Lion, G ;
Lucidarme, D ;
Forzy, G ;
Duhamel, M ;
Cousin, J ;
Ducoulombier, H ;
Wattré, P .
JOURNAL OF VIROLOGICAL METHODS, 1998, 70 (02) :183-191
[5]   In vivo and in vitro induction of MxA protein in peripheral blood mononuclear cells from patients chronically infected with hepatitis C virus [J].
Fernández, M ;
Quiroga, JA ;
Martín, J ;
Herrero, M ;
Pardo, M ;
Horisberger, MA ;
Carreño, V .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (02) :262-267
[6]   Evaluation of IFNα bioavailability by MxA mRNA in HCV patients [J].
Gilli, F ;
Sala, A ;
Bancone, C ;
Salacone, P ;
Gallo, M ;
Gaia, E ;
Bertolotto, A .
JOURNAL OF IMMUNOLOGICAL METHODS, 2002, 262 (1-2) :187-190
[7]   Identification of a single nucleotide polymorphism in the MxA gene promoter (G/T at nt-88) correlated with the response of hepatitis C patients to interferon [J].
Hijikata, M ;
Ohta, Y ;
Mishiro, S .
INTERVIROLOGY, 2000, 43 (02) :124-127
[8]   Genetic polymorphism of the MxA gene promoter and interferon responsiveness of hepatitis C patients:: Revisited by analyzing two SNP sites (-123 and-88) in vivo and in vitro [J].
Hijikata, M ;
Mishiro, S ;
Miyamoto, C ;
Furuichi, Y ;
Hashimoto, M ;
Ohta, Y .
INTERVIROLOGY, 2001, 44 (06) :379-382
[9]   The treatment of chronic viral hepatitis [J].
Hoofnagle, JH ;
DiBisceglie, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (05) :347-356
[10]   TREATMENT OF CHRONIC NON-A,NON-B HEPATITIS WITH RECOMBINANT HUMAN ALPHA-INTERFERON - A PRELIMINARY-REPORT [J].
HOOFNAGLE, JH ;
MULLEN, KD ;
JONES, DB ;
RUSTGI, V ;
DIBISCEGLIE, A ;
PETERS, M ;
WAGGONER, JG ;
PARK, Y ;
JONES, EA .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (25) :1575-1578